MX358506B - Derivados de quinolina antibacterianos. - Google Patents
Derivados de quinolina antibacterianos.Info
- Publication number
- MX358506B MX358506B MX2014013055A MX2014013055A MX358506B MX 358506 B MX358506 B MX 358506B MX 2014013055 A MX2014013055 A MX 2014013055A MX 2014013055 A MX2014013055 A MX 2014013055A MX 358506 B MX358506 B MX 358506B
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- quinoline derivatives
- pharmaceutically acceptable
- treatment
- bacterial infection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a derivados de quinolina sustituidos novedosos de acuerdo con la fórmula general (la) o la fórmula (Ib): (ver Fórmula) incluida cualquiera de sus formas estereoquímicamente isoméricas, una de sus sales farmacéuticamente aceptables, una de sus formas de N-óxido o uno de sus solvatos; los compuestos reivindicados son útiles para tratar una infección bacteriana; también se reivindica una composición que comprende un portador farmacéuticamente aceptable y, como principio activo, una cantidad terapéuticamente eficaz de los compuestos reivindicados, el uso de los compuestos o las composiciones reivindicados para la elaboración de un medicamento con el fin de tratar una infección bacteriana y un proceso para preparar los compuestos reivindicados.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12165882 | 2012-04-27 | ||
| PCT/EP2013/058697 WO2013160431A1 (en) | 2012-04-27 | 2013-04-26 | Antibacterial quinoline derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014013055A MX2014013055A (es) | 2014-12-10 |
| MX358506B true MX358506B (es) | 2018-08-22 |
Family
ID=48325651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014013055A MX358506B (es) | 2012-04-27 | 2013-04-26 | Derivados de quinolina antibacterianos. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9617244B2 (es) |
| EP (1) | EP2841426B1 (es) |
| JP (1) | JP6153603B2 (es) |
| KR (1) | KR102110366B1 (es) |
| CN (1) | CN104254528B (es) |
| AU (1) | AU2013254670B2 (es) |
| CA (1) | CA2869453C (es) |
| DK (1) | DK2841426T3 (es) |
| EA (1) | EA038350B1 (es) |
| ES (1) | ES2607879T3 (es) |
| HK (1) | HK1201520A1 (es) |
| IN (1) | IN2014MN02358A (es) |
| MX (1) | MX358506B (es) |
| PL (1) | PL2841426T3 (es) |
| PT (1) | PT2841426T (es) |
| WO (1) | WO2013160431A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013254674B2 (en) * | 2012-04-27 | 2017-02-02 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
| US11857352B2 (en) | 2016-09-06 | 2024-01-02 | The Research Foundation For The State University Of New York | Positron imaging tomography imaging agent composition and method for bacterial infection |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001503411A (ja) | 1996-10-28 | 2001-03-13 | ディパートメント オブ ジ アーミー，ユー．エス．ガバメント | 抗生物質耐性感染症の処置のための化合物、組成物および方法 |
| US6103905A (en) | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| GB0118238D0 (en) * | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
| EP1527050B1 (en) | 2002-07-25 | 2010-04-07 | Janssen Pharmaceutica N.V. | Quinoline derivatives and their use as mycobacterial inhibitors |
| CN1909907B (zh) | 2004-01-23 | 2010-06-23 | 詹森药业有限公司 | 喹啉衍生物及其在制备分枝杆菌抑制剂中的用途 |
| ES2306082T3 (es) | 2004-01-23 | 2008-11-01 | Janssen Pharmaceutica Nv | Quinolinas sustituidas y su utilizacion como inhibidores micobacterianos. |
| KR101160183B1 (ko) | 2004-01-29 | 2012-06-26 | 얀센 파마슈티카 엔.브이. | 마이코박테리아 저해제로서 사용하기 위한 퀴놀린 유도체 |
| KR20130024969A (ko) | 2004-05-28 | 2013-03-08 | 얀센 파마슈티카 엔.브이. | 약물 내성 마이코박테리아 질환 치료를 위한 치환된 퀴놀린 유도체의 용도 |
| WO2005123081A2 (en) | 2004-06-22 | 2005-12-29 | Janssen Pharmaceutica N.V. | (2-benzyl-4-{4-[1-(tetrahydrofuran-3-carbonyl)-pyrrolidin-3-yl]-piperazin-1-yl}-piperidin-1-yl)-(3,5-trifluoromethyl-phenyl))-methanone for the treatment of schizophrenia |
| DK1797115T3 (en) | 2004-09-28 | 2017-10-02 | Janssen Pharmaceutica Nv | BACTERIAL ATP SYNTHASE BINDING DOMAIN. |
| EE05394B1 (et) | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
| EE05697B1 (et) | 2005-06-08 | 2014-02-17 | Janssen Pharmaceutica N.V. | Kinoliini derivaadid kui antibakteriaalsed toimeained |
| JO2752B1 (en) | 2005-06-28 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| UA88701C2 (ru) | 2005-06-28 | 2009-11-10 | Янссэн Фармацэвтика Н.В. | Производные хинолина как антибактериальные агенты |
| JO3270B1 (ar) | 2005-06-28 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات كوينولين بصفة عوامل مضادة للبكتيريا |
| JO3077B1 (ar) | 2005-07-28 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينولين مضادة للبكتيريا |
| JO2855B1 (en) | 2005-08-03 | 2015-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| JO2952B1 (en) | 2005-08-03 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| JO2837B1 (en) | 2005-08-03 | 2014-09-15 | جانسن فارمسيتكا ان في | Quinoline derivatives acting as antibacterial agents |
| JO2685B1 (en) | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان في | Quinoline antibacterial derivatives |
| JO2683B1 (en) | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JO2970B1 (en) | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JO2684B1 (en) | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان في | Quinoline antibacterial derivatives |
| JO3271B1 (ar) | 2006-12-06 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات الكوينولين المضادة للجراثيم |
| JO2725B1 (en) * | 2006-12-06 | 2013-09-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| WO2009091324A1 (en) * | 2008-01-14 | 2009-07-23 | Jyoti Chattopadhyaya | Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| AU2013254674B2 (en) * | 2012-04-27 | 2017-02-02 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
-
2013
- 2013-04-26 US US14/391,034 patent/US9617244B2/en active Active
- 2013-04-26 EP EP13720875.7A patent/EP2841426B1/en active Active
- 2013-04-26 ES ES13720875.7T patent/ES2607879T3/es active Active
- 2013-04-26 MX MX2014013055A patent/MX358506B/es active IP Right Grant
- 2013-04-26 DK DK13720875.7T patent/DK2841426T3/en active
- 2013-04-26 PL PL13720875T patent/PL2841426T3/pl unknown
- 2013-04-26 WO PCT/EP2013/058697 patent/WO2013160431A1/en active Application Filing
- 2013-04-26 CA CA2869453A patent/CA2869453C/en active Active
- 2013-04-26 IN IN2358MUN2014 patent/IN2014MN02358A/en unknown
- 2013-04-26 EA EA201491971A patent/EA038350B1/ru unknown
- 2013-04-26 JP JP2015507547A patent/JP6153603B2/ja active Active
- 2013-04-26 KR KR1020147030645A patent/KR102110366B1/ko active IP Right Grant
- 2013-04-26 PT PT137208757T patent/PT2841426T/pt unknown
- 2013-04-26 AU AU2013254670A patent/AU2013254670B2/en active Active
- 2013-04-26 CN CN201380021822.1A patent/CN104254528B/zh active Active
-
2015
- 2015-02-27 HK HK15101961.6A patent/HK1201520A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013160431A1 (en) | 2013-10-31 |
| JP2015514795A (ja) | 2015-05-21 |
| EP2841426A1 (en) | 2015-03-04 |
| IN2014MN02358A (es) | 2015-08-14 |
| MX2014013055A (es) | 2014-12-10 |
| CN104254528A (zh) | 2014-12-31 |
| US9617244B2 (en) | 2017-04-11 |
| PL2841426T3 (pl) | 2017-03-31 |
| CA2869453C (en) | 2021-03-02 |
| AU2013254670A1 (en) | 2014-10-16 |
| AU2013254670B2 (en) | 2017-03-30 |
| ES2607879T3 (es) | 2017-04-04 |
| EA201491971A1 (ru) | 2015-02-27 |
| US20150051244A1 (en) | 2015-02-19 |
| EA038350B1 (ru) | 2021-08-12 |
| HK1201520A1 (en) | 2015-09-04 |
| PT2841426T (pt) | 2016-11-23 |
| CA2869453A1 (en) | 2013-10-31 |
| KR20150013148A (ko) | 2015-02-04 |
| CN104254528B (zh) | 2017-06-06 |
| DK2841426T3 (en) | 2017-01-09 |
| KR102110366B1 (ko) | 2020-05-14 |
| EP2841426B1 (en) | 2016-09-28 |
| JP6153603B2 (ja) | 2017-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO3271B1 (ar) | مشتقات الكوينولين المضادة للجراثيم | |
| PH12020551089A1 (en) | Pyrrolopyrimidine compounds used as tlr7 agonist | |
| NZ710854A (en) | Quinolines derivatives as novel anticancer agents | |
| MY188960A (en) | Cyclic boronic acid ester derivatives and therapeutic uses thereof | |
| GEP20217235B (en) | Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds | |
| UA101305C2 (ru) | Антибактериальные производные хинолина | |
| MX2014013056A (es) | Derivados de quinolina antibacterianos. | |
| HK1137431A1 (en) | Antibacterial quinoline derivatives | |
| JO2970B1 (en) | Quinoline antibacterial derivatives | |
| WO2013106756A3 (en) | Antimicrobial agents | |
| JO2685B1 (en) | Quinoline antibacterial derivatives | |
| MX2014013055A (es) | Derivados de quinolina antibacterianos. | |
| UA101307C2 (ru) | Антибактериальные производные хинолина | |
| NZ700507A (en) | Pyrimidine derivatives for the treatment of bacterial diseases | |
| MX2015012575A (es) | Novedosos derivados de acrilamida como agentes contra la malaria. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |